Kailin Xu

A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial

Zhiling Yan, Jiang Cao, Hai Cheng et al. · The Lancet Haematology · 2019 · 310 citations

Hematological Malignancy, Medicine, Immunology +9

Potent anti‐leukemia activities of humanized CD19‐targeted Chimeric antigen receptor T (CAR‐T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

Jiang Cao, Gang Wang, Hai Cheng et al. · American Journal of Hematology · 2018 · 170 citations · Full text

Topology-Aware Convolutional Neural Network for Efficient Skeleton-Based Action Recognition

Kailin Xu, Fanfan Ye, Qiaoyong Zhong et al. · Proceedings of the AAAI Conference on Artificial Intelligence · 2022 · 152 citations · Full text

Geometric Learning, Convolutional Neural Network, Engineering +16

Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial

Hong‐Hu Zhu, Depei Wu, Xin Du et al. · The Lancet Oncology · 2018 · 143 citations

Hematological Malignancy, Retinoic Acid Versus, Oncology +6

NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis

Jianlin Qiao, Xiaoqing Wu, Qi Luo et al. · Haematologica · 2018 · 117 citations · Full text